Adoption of new therapies in the treatment of Hepatitis: a verification of the accuracy of budget impact analysis to guide investment decisions.

Daniel Resende Faleiros Everton Nunes da Silva Andreia C Santos Brian B Godman Ramon Gonçalves Pereira Augusto Afonso Guerra Junior

Published in: Expert review of pharmacoeconomics & outcomes research (2022)

This study demonstrates appreciable divergence (US$156.58 million) between the theoretical budget impact and RWE expenditures due to underestimated purchase prices and overestimated populations. The greater the degree of accuracy the more reliable and usable BIAs become for decision-making.

Keyphrases

decision making
electronic health record
smoking cessation